Immunitor USA Inc. CEO Joins Immune Network Ltd. Board of Directors

VANCOUVER, British Columbia, Feb. 14, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) is pleased to announce that a co-founder of Immunitor, Dr. Aldar Bourinbaiar, has joined Immune's board of directors. Immune Network is completing its acquisition of 50% of Immunitor Inc., a company which has global rights to a patented product called V5, clinically shown to be effective against hepatitis B, hepatitis C, and recently demonstrated as a potent immune adjunct for chemotherapeutic management of tuberculosis, including drug resistant MDR-TB and TB/HIV dual infection.

Back to news